Value proposition

Mitsubishi Tanabe Pharma America, Inc. (MTPA) was launched in 2016 as a wholly-owned subsidiary of Mitsubishi Tanabe Pharma Corporation (MTPC) – one of the world’s oldest pharmaceutical companies. Driving scientific discovery and innovation is at the center of everything we do, and it’s more than just a passion – it’s a commitment. MTPA is dedicated to developing innovative treatments to help those who are living with serious and debilitating diseases.

Please see our LinkedIn community guidelines here: http://www.mt-pharma-america.com/pdf/LinkedIn-Community-Guidelines.pdf

pharmaceutical products, amyotrophic lateral sclerosis, rare disease, innovation, research and development, and global business